DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer

Benjamin A. Rybicki, David V. Conti, Andrea Moreira, Mine Cicek, Graham Casey, John S. Witte

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

The X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) genes are involved in base excision repair and nucleotide excision repair of DNA repair pathways, respectively. A growing body of evidence suggests that XRCC1 and XPD are important in environmentally induced cancers, and polymorphisms in both genes have been identified. To determine whether the XRCC1 (codon Arg399Gln) and XPD (codon Asp312Asn and codon Lys751Gln) polymorphisms are associated with prostate cancer susceptibility, we genotyped these polymorphisms in a primarily Caucasian sample of 506 sibships (n = 1,117) ascertained through a brother with prostate cancer. Sibships were analyzed with a Cox proportional hazards model with age at prostate cancer diagnosis as the outcome. Of the three polymorphisms investigated, only the XPD codon 312 Asn/Asn genotype had an odds ratio (OR) significantly different from one (OR, 1.61; 95% CI, 1.03-2.53). Analyses stratified by the clinical characteristics of affected brothers in the sibship did not reveal any significant heterogeneity in risk. In exploring two-way gene interactions, we found a markedly elevated risk for the combination of the XPD codon 312 Asn/Asn and XRCC1 codon 399 Gln/Gln genotypes (OR, 4.81; 95% CI, 1.66-13.97). In summary, our results suggest that the XPD codon 312 Asn allele may exert a modest positive effect on prostate cancer risk when two copies of the allele are present, and this effect is enhanced by the XRCC codon 399 Gln allele in its recessive state.

Original languageEnglish (US)
Pages (from-to)23-29
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume13
Issue number1
DOIs
StatePublished - Jan 2004
Externally publishedYes

Fingerprint

Xeroderma Pigmentosum
Codon
DNA Repair
Prostatic Neoplasms
X-Rays
Genes
Alleles
Odds Ratio
Genotype
Proportional Hazards Models

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer. / Rybicki, Benjamin A.; Conti, David V.; Moreira, Andrea; Cicek, Mine; Casey, Graham; Witte, John S.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 13, No. 1, 01.2004, p. 23-29.

Research output: Contribution to journalArticle

Rybicki, Benjamin A. ; Conti, David V. ; Moreira, Andrea ; Cicek, Mine ; Casey, Graham ; Witte, John S. / DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer. In: Cancer Epidemiology Biomarkers and Prevention. 2004 ; Vol. 13, No. 1. pp. 23-29.
@article{eebbaa33d5ed46eeac1dd403bb590482,
title = "DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer",
abstract = "The X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) genes are involved in base excision repair and nucleotide excision repair of DNA repair pathways, respectively. A growing body of evidence suggests that XRCC1 and XPD are important in environmentally induced cancers, and polymorphisms in both genes have been identified. To determine whether the XRCC1 (codon Arg399Gln) and XPD (codon Asp312Asn and codon Lys751Gln) polymorphisms are associated with prostate cancer susceptibility, we genotyped these polymorphisms in a primarily Caucasian sample of 506 sibships (n = 1,117) ascertained through a brother with prostate cancer. Sibships were analyzed with a Cox proportional hazards model with age at prostate cancer diagnosis as the outcome. Of the three polymorphisms investigated, only the XPD codon 312 Asn/Asn genotype had an odds ratio (OR) significantly different from one (OR, 1.61; 95{\%} CI, 1.03-2.53). Analyses stratified by the clinical characteristics of affected brothers in the sibship did not reveal any significant heterogeneity in risk. In exploring two-way gene interactions, we found a markedly elevated risk for the combination of the XPD codon 312 Asn/Asn and XRCC1 codon 399 Gln/Gln genotypes (OR, 4.81; 95{\%} CI, 1.66-13.97). In summary, our results suggest that the XPD codon 312 Asn allele may exert a modest positive effect on prostate cancer risk when two copies of the allele are present, and this effect is enhanced by the XRCC codon 399 Gln allele in its recessive state.",
author = "Rybicki, {Benjamin A.} and Conti, {David V.} and Andrea Moreira and Mine Cicek and Graham Casey and Witte, {John S.}",
year = "2004",
month = "1",
doi = "10.1158/1055-9965.EPI-03-0053",
language = "English (US)",
volume = "13",
pages = "23--29",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer

AU - Rybicki, Benjamin A.

AU - Conti, David V.

AU - Moreira, Andrea

AU - Cicek, Mine

AU - Casey, Graham

AU - Witte, John S.

PY - 2004/1

Y1 - 2004/1

N2 - The X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) genes are involved in base excision repair and nucleotide excision repair of DNA repair pathways, respectively. A growing body of evidence suggests that XRCC1 and XPD are important in environmentally induced cancers, and polymorphisms in both genes have been identified. To determine whether the XRCC1 (codon Arg399Gln) and XPD (codon Asp312Asn and codon Lys751Gln) polymorphisms are associated with prostate cancer susceptibility, we genotyped these polymorphisms in a primarily Caucasian sample of 506 sibships (n = 1,117) ascertained through a brother with prostate cancer. Sibships were analyzed with a Cox proportional hazards model with age at prostate cancer diagnosis as the outcome. Of the three polymorphisms investigated, only the XPD codon 312 Asn/Asn genotype had an odds ratio (OR) significantly different from one (OR, 1.61; 95% CI, 1.03-2.53). Analyses stratified by the clinical characteristics of affected brothers in the sibship did not reveal any significant heterogeneity in risk. In exploring two-way gene interactions, we found a markedly elevated risk for the combination of the XPD codon 312 Asn/Asn and XRCC1 codon 399 Gln/Gln genotypes (OR, 4.81; 95% CI, 1.66-13.97). In summary, our results suggest that the XPD codon 312 Asn allele may exert a modest positive effect on prostate cancer risk when two copies of the allele are present, and this effect is enhanced by the XRCC codon 399 Gln allele in its recessive state.

AB - The X-ray repair cross-complementing group 1 (XRCC1) and xeroderma pigmentosum group D (XPD) genes are involved in base excision repair and nucleotide excision repair of DNA repair pathways, respectively. A growing body of evidence suggests that XRCC1 and XPD are important in environmentally induced cancers, and polymorphisms in both genes have been identified. To determine whether the XRCC1 (codon Arg399Gln) and XPD (codon Asp312Asn and codon Lys751Gln) polymorphisms are associated with prostate cancer susceptibility, we genotyped these polymorphisms in a primarily Caucasian sample of 506 sibships (n = 1,117) ascertained through a brother with prostate cancer. Sibships were analyzed with a Cox proportional hazards model with age at prostate cancer diagnosis as the outcome. Of the three polymorphisms investigated, only the XPD codon 312 Asn/Asn genotype had an odds ratio (OR) significantly different from one (OR, 1.61; 95% CI, 1.03-2.53). Analyses stratified by the clinical characteristics of affected brothers in the sibship did not reveal any significant heterogeneity in risk. In exploring two-way gene interactions, we found a markedly elevated risk for the combination of the XPD codon 312 Asn/Asn and XRCC1 codon 399 Gln/Gln genotypes (OR, 4.81; 95% CI, 1.66-13.97). In summary, our results suggest that the XPD codon 312 Asn allele may exert a modest positive effect on prostate cancer risk when two copies of the allele are present, and this effect is enhanced by the XRCC codon 399 Gln allele in its recessive state.

UR - http://www.scopus.com/inward/record.url?scp=1642568757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1642568757&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-03-0053

DO - 10.1158/1055-9965.EPI-03-0053

M3 - Article

C2 - 14744728

AN - SCOPUS:1642568757

VL - 13

SP - 23

EP - 29

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -